Cargando…

Correction to: Antibody Correlates of Protection From Severe Respiratory Syncytial Virus Disease in a Vaccine Efficacy Trial

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166513/ https://www.ncbi.nlm.nih.gov/pubmed/37168800 http://dx.doi.org/10.1093/ofid/ofad250

Ejemplares similares

Antibody Correlates of Protection From Severe Respiratory Syncytial Virus Disease in a Vaccine Efficacy Trial
por: Fong, Youyi, et al.
Publicado: (2023)

Correction to: All Infants Are at Risk of Developing Medically Attended Respiratory Syncytial Virus Lower Respiratory Tract Infection and Deserve Protection
Publicado: (2022)

Author Correction: An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus
por: Zuniga, Armando, et al.
Publicado: (2021)

Vaccination of pregnant women with respiratory syncytial virus vaccine and protection of their infants
por: Madhi, Shabir A, et al.
Publicado: (2020)

Author Correction: Airway response to respiratory syncytial virus has incidental antibacterial effects
por: Sande, Charles J., et al.
Publicado: (2019)

Immunogenicity and Protective Efficacy of a Dual Subunit Vaccine Against Respiratory Syncytial Virus and Influenza Virus
por: Park, Min-Hee, et al.
Publicado: (2012)

Correction: A randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection
por: Walsh, Paul, et al.
Publicado: (2021)

Correction: A specific sequence in the genome of respiratory syncytial virus regulates the generation of copy-back defective viral genomes
por: Sun, Yan, et al.
Publicado: (2019)

Protective Efficacy and Immunogenicity of a Combinatory DNA Vaccine against Influenza A Virus and the Respiratory Syncytial Virus
por: Stab, Viktoria, et al.
Publicado: (2013)

Severe Respiratory Syncytial Virus Infection
por: Kashiwagi, Yasuyo, et al.
Publicado: (2019)

Human Metapneumovirus and Severity of Respiratory Syncytial Virus Disease
por: Lazar, Isaac, et al.
Publicado: (2004)

Publisher Correction: Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus
por: Lin, Gu-Lung, et al.
Publicado: (2021)

Correction: Correction: Molecular Characterization of Circulating Respiratory Syncytial Virus (RSV) Genotypes in Gilgit Baltistan Province of Pakistan during 2011–2012 Winter Season
Publicado: (2016)

Protection against Bovine Respiratory Syncytial Virus Afforded by Maternal Antibodies from Cows Immunized with an Inactivated Vaccine
por: Meyer, Gilles, et al.
Publicado: (2023)

Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B
por: Hause, Anne M., et al.
Publicado: (2017)

Correction: Effects of Chronologic Age and Young Child Exposure on Respiratory Syncytial Virus Disease among US Preterm Infants Born at 32 to 35 Weeks Gestation
por: Simões, Eric A. F., et al.
Publicado: (2016)

Respiratory Syncytial Virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice
por: Torres, Juan Pablo, et al.
Publicado: (2010)

Evaluation of Protective Efficacy of Respiratory Syncytial Virus Vaccine against A and B Subgroup Human Isolates in Korea
por: Jang, Ji-Eun, et al.
Publicado: (2011)

Natural killer cell activation by respiratory syncytial virus‐specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc‐glycosylation
por: van Erp, Elisabeth A, et al.
Publicado: (2020)

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
por: Graham, Barney S., et al.
Publicado: (2013)

The road to approved vaccines for respiratory syncytial virus
por: Ruckwardt, Tracy J.
Publicado: (2023)

Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease
por: O’Hagan, Shaun, et al.
Publicado: (2023)

AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats
por: Sawada, Akihito, et al.
Publicado: (2011)

Influenza and respiratory syncytial virus (RSV) vaccines for infants: Safety, immunogenicity, and efficacy
por: Beeler, Judy A., et al.
Publicado: (2013)

Correction: Molecular Characterization of Circulating Respiratory Syncytial Virus (RSV) Genotypes in Gilgit Baltistan Province of Pakistan during 2011–2012 Winter Season
por: Aamir, Uzma Bashir, et al.
Publicado: (2015)

Publisher Correction: Clinical evaluation of fully automated molecular diagnostic system “Simprova” for influenza virus, respiratory syncytial virus, and human metapneumovirus
por: Takayama, Ikuyo, et al.
Publicado: (2020)

Correction: The significance of human respiratory syncytial virus (HRSV) in children from Ghana with acute lower respiratory tract infection: A molecular epidemiological analysis, 2006 and 2013-2014
por: Obodai, Evangeline, et al.
Publicado: (2019)

In Vitro Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants
por: van Erp, Elisabeth A., et al.
Publicado: (2017)

Correction: Correlative Gene Expression to Protective Seroconversion In Rift Valley Vaccinates
por: Laughin, Richard C., et al.
Publicado: (2016)

Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses
por: Raman, Sathya N. Thulasi, et al.
Publicado: (2023)

Incorporating efficacy data from initial trials into subsequent evaluations: Application to vaccines against respiratory syncytial virus
por: Warren, Joshua L., et al.
Publicado: (2023)

Molecular Epidemiology and Disease Severity of Human Respiratory Syncytial Virus in Vietnam
por: Tran, Dinh Nguyen, et al.
Publicado: (2013)

Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013)

Respiratory syncytial virus
por: Ruuskanen, Olli, et al.
Publicado: (1993)

Respiratory syncytial virus
por: Munoz, Flor M., et al.
Publicado: (2020)

Human Metapneumovirus in Severe Respiratory Syncytial Virus Bronchiolitis
por: Greensill, Julie, et al.
Publicado: (2003)

Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
por: Blanco, Jorge C. G., et al.
Publicado: (2018)

Respiratory Syncytial Virus: Current Progress in Vaccine Development
por: Rudraraju, Rajeev, et al.
Publicado: (2013)

Developing Vaccines against Respiratory Syncytial Virus Infection
por: Chang, Jun
Publicado: (2011)

Fail-Fast in Respiratory Syncytial Virus Vaccine Development
por: Besteman, Sjanna B., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v1a9i8lhv6cmrit8fr5df38e9k